Berno Müller & Carla Solimano
Digitalization & Pharma – Optimization of Patient Care Including Expertise Beyond the Pill
The path from diagnosis to treatment is rarely straightforward—fragmented communication, delayed detection, and low adherence often stand in the way of better outcomes. As healthcare becomes more complex, digital innovation is beginning to weave these loose ends together—turning expertise, technology, and touchpoints into connected, continuous care.
In an era of limited resources, pharmaceutical value will increasingly depend on how well companies combine therapeutic expertise with digital tools to optimize care across the entire patient journey.
Not long ago, prescribing a medication marked the endpoint of a care process. Today, it’s increasingly just the beginning. Between first symptoms and lasting outcomes lies a growing web of needs—early detection, diagnostics, education, adherence, behavioral support. And in that web, digital tools are no longer optional. From omnichannel communication to DIGAs, from AI-assisted screening to app-based treatment guidance, a new role for pharma is taking shape: not just as the maker of medicines, but as a connector—linking knowledge, care structures, and patient realities into one seamless experience.
When Care Extends Beyond the Pill:
Rethinking Pharma’s Role in the System
What you’ll learn
-
Why fixed communication strategies fall short in modern care environments
-
How digital channels and real-world data improve access, engagement, and outcomes
-
What AI-driven diagnostics and virtual screening tools can contribute to prevention and early detection
-
How apps and digital therapeutics support adherence in chronic disease management
-
What it takes to turn pharmaceutical knowledge into scalable, integrated service models
Medical doctor by training with more than five years of clinical expertise in traumatology, general medicine, nutritional and emergency medicine. More than 25 years’ experience in pharmaceutical industry in leading position both in pre-clinical and clinical development and medical affairs including regulatory, pharmacovigilance, and quality. Different assignments of lectureship at the University of Applied Science Neu-Ulm and the Dual University Baden-Württemberg covering innovation and research.
About the Author
Dr. med. Berno Müller
Connect
Experienced professional with more than 15 years in the pharmaceutical industry across different geographies with a successful track record in a variety of leadership roles, including brand management, omnichannel strategy, and commercial excellence. International Business Degree from ESB Reutlingen Business School with specialization in Marketing, MBA from CSU East Bay and Master’s in Digital Business from EU Business School.
About the Author
Carla Solimano, MBA
Connect
